KEGG pathway analysis revealed that the compound was most likely to initiate BRCA through several key pathways, including the phosphatidylinositol 3-kinase-protein kinase B (PI3K-Akt) signaling pathway, MicroRNAs in cancer and Chemical carcinogenesis − receptor activation (Fig 6). The gene discussed is AKT1; the disease is cancer.